Canaccord Genuity maintained a Buy rating on AngioDynamics (NASDAQ: ANGO), and cut the price target to $17.50 (from $19.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Piper Jaffray Cuts Price target on AngioDynamics (ANGO) Following 1Q16 Results October 9, 2015 8:12 AM AngioDynamics (ANGO) Reports In-Line Q1 EPS, Offers Q2 and FY16 GuidanceOctober 8, 2015 4:04 PM AngioDynamics Reports Fiscal 2016 First Quarter ResultsOctober 8, 2015 4:01 PM Trading Radar for 10/8: Alcoa (AA), Domino's Pizza (DPZ), International Speedway (ISCA), Ruby Tuesday (RT) ReportOctober 7, 2015 2:44 PM